-
1
-
-
9244260186
-
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis
-
1. Broomé U, Olsson R, Lööf L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38:610-615.
-
(1996)
Gut
, vol.38
, pp. 610-615
-
-
Broomé, U.1
Olsson, R.2
Lööf, L.3
Bodemar, G.4
Hultcrantz, R.5
Danielsson, A.6
-
2
-
-
0031038847
-
Primary sclerosing cholangitis in Japan: Analysis of 192 cases
-
2. Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan: analysis of 192 cases. J Gastroenterol 1997; 32:134-137.
-
(1997)
J Gastroenterol
, vol.32
, pp. 134-137
-
-
Takikawa, H.1
Manabe, T.2
-
3
-
-
0027971759
-
Epidemiology of primary sclerosing cholangitis in Spain
-
Spanish Association for the Study of the Liver.
-
3. Escorsell A, Parés A, Rodés J, Solís HJ, Miras M, de la Morena E. Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J Hepatol 1994; 21:787-791.
-
(1994)
J Hepatol
, vol.21
, pp. 787-791
-
-
Escorsell, A.1
Parés, A.2
Rodés, J.3
Solís, H.J.4
Miras, M.5
De La Morena, E.6
-
4
-
-
0030014102
-
Primary sclerosing cholangitis: Clinical presentation, natural history and prognostic variables: An Italian multicentre study
-
The Italian PSC Study Group.
-
4. Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Eur J Gastroenterol Hepatol 1996; 8:685-691.
-
(1996)
Eur J Gastroenterol Hepatol
, vol.8
, pp. 685-691
-
-
Okolicsanyi, L.1
Fabris, L.2
Viaggi, S.3
Carulli, N.4
Podda, M.5
Ricci, G.6
-
5
-
-
0025760441
-
Natural history and prognostic variables in primary sclerosing cholangitis
-
5. Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, Williams R. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100:1710-1717.
-
(1991)
Gastroenterology
, vol.100
, pp. 1710-1717
-
-
Farrant, J.M.1
Hayllar, K.M.2
Wilkinson, M.L.3
Karani, J.4
Portmann, B.C.5
Westaby, D.6
Williams, R.7
-
6
-
-
0028625484
-
Risk factors in primary sclerosing cholangitis
-
6. Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F. Risk factors in primary sclerosing cholangitis. J Hepatol 1994; 21:1061-1066.
-
(1994)
J Hepatol
, vol.21
, pp. 1061-1066
-
-
Schrumpf, E.1
Abdelnoor, M.2
Fausa, O.3
Elgjo, K.4
Jenssen, E.5
Kolmannskog, F.6
-
7
-
-
0025856531
-
Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis
-
7. Olsson R, Danielsson A, Järnerot G, Lindström E, Lööf L, Rolny P, Rydén BO, Tysk C, Wallerstedt S. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991; 100:1319-1323.
-
(1991)
Gastroenterology
, vol.100
, pp. 1319-1323
-
-
Olsson, R.1
Danielsson, A.2
Järnerot, G.3
Lindström, E.4
Lööf, L.5
Rolny, P.6
Rydén, B.O.7
Tysk, C.8
Wallerstedt, S.9
-
8
-
-
0021058099
-
Ulcerative colitis and persistent liver dysfunction
-
8. Shepherd HA, Selby WS, Chapman RW, Nolan D, Barbatis C, McGee JO, Jewell DP. Ulcerative colitis and persistent liver dysfunction. Q J Med 1983; 52:503-513.
-
(1983)
Q J Med
, vol.52
, pp. 503-513
-
-
Shepherd, H.A.1
Selby, W.S.2
Chapman, R.W.3
Nolan, D.4
Barbatis, C.5
McGee, J.O.6
Jewell, D.P.7
-
9
-
-
0030788761
-
Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease
-
9. Rasmussen HH, Fallingborg JF, Mortensen PB, Vyberg M, Tage JU, Rasmussen SN. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease. Scand J Gastroenterol 1997; 32:604-610.
-
(1997)
Scand J Gastroenterol
, vol.32
, pp. 604-610
-
-
Rasmussen, H.H.1
Fallingborg, J.F.2
Mortensen, P.B.3
Vyberg, M.4
Tage, J.U.5
Rasmussen, S.N.6
-
10
-
-
0019204917
-
Primary sclerosing cholangitis: A review of its clinical features, cholangiography, and hepatic histology
-
10. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21:870-877.
-
(1980)
Gut
, vol.21
, pp. 870-877
-
-
Chapman, R.W.1
Arborgh, B.A.2
Rhodes, J.M.3
Summerfield, J.A.4
Dick, R.5
Scheuer, P.J.6
Sherlock, S.7
-
11
-
-
0029848707
-
Autoimmune hepatitis. Definition-classification-histopathology-immunopathogenesis
-
11. Meyer BK, Dienes HP. Autoimmune hepatitis. Definition-classification-histopathology-immunopathogenesis. Virchows Arch 1996; 429:1-12.
-
(1996)
Virchows Arch
, vol.429
, pp. 1-12
-
-
Meyer, B.K.1
Dienes, H.P.2
-
12
-
-
0023219637
-
Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients
-
12. Heizberg JH, Petersen JM, Boyer JL. Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology 1987; 92:1869-1875.
-
(1987)
Gastroenterology
, vol.92
, pp. 1869-1875
-
-
Heizberg, J.H.1
Petersen, J.M.2
Boyer, J.L.3
-
13
-
-
0023279107
-
Primary sclerosing cholangitis: A long-term follow-up study
-
13. Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, Gjone E. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1987; 22:655-664.
-
(1987)
Scand J Gastroenterol
, vol.22
, pp. 655-664
-
-
Aadland, E.1
Schrumpf, E.2
Fausa, O.3
Elgjo, K.4
Heilo, A.5
Aakhus, T.6
Gjone, E.7
-
14
-
-
0029982558
-
Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis
-
14. Boberg KM, Fausa O, Haaland T, Hotter E, Mellbye OJ, Spurkland A, Schrumpf E. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 1996; 23:1369-1376.
-
(1996)
Hepatology
, vol.23
, pp. 1369-1376
-
-
Boberg, K.M.1
Fausa, O.2
Haaland, T.3
Hotter, E.4
Mellbye, O.J.5
Spurkland, A.6
Schrumpf, E.7
-
15
-
-
0023217721
-
An autoantibody profile in primary sclerosing cholangitis
-
15. Zauli D, Schrumpf E, Crespi C, Cassani F, Fausa O, Aadland E. An autoantibody profile in primary sclerosing cholangitis. J Hepatol 1987; 5:14-18.
-
(1987)
J Hepatol
, vol.5
, pp. 14-18
-
-
Zauli, D.1
Schrumpf, E.2
Crespi, C.3
Cassani, F.4
Fausa, O.5
Aadland, E.6
-
16
-
-
0025910090
-
Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitic
-
16. Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitic. Gastroenterology 1991; 100:1385-1391.
-
(1991)
Gastroenterology
, vol.100
, pp. 1385-1391
-
-
Duerr, R.H.1
Targan, S.R.2
Landers, C.J.3
LaRusso, N.F.4
Lindsay, K.L.5
Wiesner, R.H.6
Shanahan, F.7
-
17
-
-
0026518819
-
Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis
-
17. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992; 33:657-662.
-
(1992)
Gut
, vol.33
, pp. 657-662
-
-
Seibold, F.1
Weber, P.2
Klein, R.3
Berg, P.A.4
Wiedmann, K.H.5
-
18
-
-
0026709891
-
Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique
-
18. Lo SK, Fleming KA, Chapman RW. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut 1992; 33:1370-1375.
-
(1992)
Gut
, vol.33
, pp. 1370-1375
-
-
Lo, S.K.1
Fleming, K.A.2
Chapman, R.W.3
-
19
-
-
0029864461
-
Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: Prevalence, titre, and IgG subclass
-
19. Bansi DS, Fleming KA, Chapman RW. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass. Gut 1996; 38:384-389.
-
(1996)
Gut
, vol.38
, pp. 384-389
-
-
Bansi, D.S.1
Fleming, K.A.2
Chapman, R.W.3
-
20
-
-
0028988103
-
High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis
-
20. Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 1995; 108:1159-1166.
-
(1995)
Gastroenterology
, vol.108
, pp. 1159-1166
-
-
Targan, S.R.1
Landers, C.2
Vidrich, A.3
Czaja, A.J.4
-
21
-
-
8544276587
-
Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: A comparison of the alkaline phosphatase and immunofluorescent techniques
-
21. Bansi DS, Bauducci M, Bergqvist A, Boberg K, Broomé U, Chapman R, et al. Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques. Eur J Gastroenterol Hepatol 1997; 9:575-580.
-
(1997)
Eur J Gastroenterol Hepatol
, vol.9
, pp. 575-580
-
-
Bansi, D.S.1
Bauducci, M.2
Bergqvist, A.3
Boberg, K.4
Broomé, U.5
Chapman, R.6
-
22
-
-
0028128047
-
Liver disease in ulcerative colitis: An epidemiological and follow up study in the county of Stockholm
-
22. Broomé U, Glaumann H, Hellers G, Nilsson B, Sörstad J, Hultcrantz R. Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm. Gut 1994; 35:84-89.
-
(1994)
Gut
, vol.35
, pp. 84-89
-
-
Broomé, U.1
Glaumann, H.2
Hellers, G.3
Nilsson, B.4
Sörstad, J.5
Hultcrantz, R.6
-
23
-
-
0025727705
-
Small-duct primary sclerosing cholangitis
-
23. Ludwig J. Small-duct primary sclerosing cholangitis. Semin Liver Dis 1991; 11:11-17.
-
(1991)
Semin Liver Dis
, vol.11
, pp. 11-17
-
-
Ludwig, J.1
-
24
-
-
0024542414
-
Floxuridine-induced sclerosing cholangitis: An ischemic cholangiopathy?
-
24. Ludwig J, Kim CH, Wiesner RH, Krom RA. Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy? Hepatology 1989; 9:215-218.
-
(1989)
Hepatology
, vol.9
, pp. 215-218
-
-
Ludwig, J.1
Kim, C.H.2
Wiesner, R.H.3
Krom, R.A.4
-
25
-
-
0028085138
-
Sclerosing cholangitis in children
-
25. Debray D, Pariente D, Urvoas E, Hadchouel M, Bernard O. Sclerosing cholangitis in children. J Pediatr 1994; 124:49-56.
-
(1994)
J Pediatr
, vol.124
, pp. 49-56
-
-
Debray, D.1
Pariente, D.2
Urvoas, E.3
Hadchouel, M.4
Bernard, O.5
-
26
-
-
0024554680
-
Acquired immunodeficiency syndrome cholangiopathy: Spectrum of disease
-
26. Cello JP. Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am J Med 1989; 86:539-546.
-
(1989)
Am J Med
, vol.86
, pp. 539-546
-
-
Cello, J.P.1
-
27
-
-
0024384431
-
Surgical pathology of the syndrome of primary sclerosing cholangitis
-
27. Ludwig J. Surgical pathology of the syndrome of primary sclerosing cholangitis. Am J Surg Pathol 1989; 13 Suppl 1:43-49.
-
(1989)
Am J Surg Pathol
, vol.13
, Issue.SUPPL. 1
, pp. 43-49
-
-
Ludwig, J.1
-
28
-
-
0029436402
-
Histopathology of cholestasis
-
28. Desmet VJ. Histopathology of cholestasis. Verh Dtsch Ges Pathol 1995; 79:233-240.
-
(1995)
Verh Dtsch Ges Pathol
, vol.79
, pp. 233-240
-
-
Desmet, V.J.1
-
29
-
-
0003096501
-
Histopathology of primary sclerosing cholangitis
-
Manns MP, et al. (eds.) Dordrecht: Kluwer Academic Publishers
-
29. Ludwig J. Histopathology of primary sclerosing cholangitis. In Primary Sclerosing Cholangitis. Manns MP, et al. (eds.) Dordrecht: Kluwer Academic Publishers, 1998, pp. 14-21.
-
(1998)
Primary Sclerosing Cholangitis
, pp. 14-21
-
-
Ludwig, J.1
-
30
-
-
0019776982
-
Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis
-
30. Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1981; 1:632-640.
-
(1981)
Hepatology
, vol.1
, pp. 632-640
-
-
Ludwig, J.1
Barham, S.S.2
LaRusso, N.F.3
Elveback, L.R.4
Wiesner, R.H.5
McCall, J.T.6
-
31
-
-
0020565736
-
Primary sclerosing cholangitis: Findings on cholangiography and pancreatography
-
31. MacCarty RL, LaRusso NF, Wiesner RH, Ludwig J. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology 1983; 149:39-44.
-
(1983)
Radiology
, vol.149
, pp. 39-44
-
-
MacCarty, R.L.1
LaRusso, N.F.2
Wiesner, R.H.3
Ludwig, J.4
-
32
-
-
0025137865
-
Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects
-
32. Rabinovitz M, Gavaler JS, Schade RR, Dindzans VJ, Chien MC, Van Thiel DH. Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects. Hepatology 1990; 11:7-11.
-
(1990)
Hepatology
, vol.11
, pp. 7-11
-
-
Rabinovitz, M.1
Gavaler, J.S.2
Schade, R.R.3
Dindzans, V.J.4
Chien, M.C.5
Van Thiel, D.H.6
-
33
-
-
0018960442
-
Clinicopathological features of the syndrome of primary sclerosing cholangitis
-
33. Wiesner RH, LaRusso N. Clinicopathological features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79:200-206.
-
(1980)
Gastroenterology
, vol.79
, pp. 200-206
-
-
Wiesner, R.H.1
LaRusso, N.2
-
34
-
-
0023221248
-
Outcome of primary sclerosing cholangitis. Analysis of long-term observation of 38 patients
-
34. Lebovics E, Palmer M, Woo J, Schaffner F. Outcome of primary sclerosing cholangitis. Analysis of long-term observation of 38 patients. Arch Intern Med 1987; 147:729-731.
-
(1987)
Arch Intern Med
, vol.147
, pp. 729-731
-
-
Lebovics, E.1
Palmer, M.2
Woo, J.3
Schaffner, F.4
-
35
-
-
0024414279
-
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
-
35. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10:430-136.
-
(1989)
Hepatology
, vol.10
, pp. 430-1136
-
-
Wiesner, R.H.1
Grambsch, P.M.2
Dickson, E.R.3
Ludwig, J.4
MacCarty, R.L.5
Hunter, E.B.6
-
36
-
-
0025259858
-
Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease
-
36. Porayko MK, Wiesner RH, LaRusso NF, Ludwig J, MacCarty RL, Steiner BL, et al. Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology 1990; 98:1594-1602.
-
(1990)
Gastroenterology
, vol.98
, pp. 1594-1602
-
-
Porayko, M.K.1
Wiesner, R.H.2
LaRusso, N.F.3
Ludwig, J.4
MacCarty, R.L.5
Steiner, B.L.6
-
37
-
-
0025803808
-
Cholangiocarcinoma complicating primary sclerosing cholangitis
-
37. Rosen CB, Nagorney DM. Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 1991; 11:26-30.
-
(1991)
Semin Liver Dis
, vol.11
, pp. 26-30
-
-
Rosen, C.B.1
Nagorney, D.M.2
-
38
-
-
0025283406
-
Advances in primary sclerosing cholangitis
-
38. Lindor KD, Wiesner RH, MacCarty RL, Ludwig J, LaRusso NF. Advances in primary sclerosing cholangitis. Am J Med 1990; 89:73-80.
-
(1990)
Am J Med
, vol.89
, pp. 73-80
-
-
Lindor, K.D.1
Wiesner, R.H.2
MacCarty, R.L.3
Ludwig, J.4
Larusso, N.F.5
-
39
-
-
0028795328
-
Primary sclerosing cholangitis: Liver transplantation or biliary surgery
-
39. Farges O, Malassagne B, Sebagh M, Bismuth H. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery 1995; 117:146-155.
-
(1995)
Surgery
, vol.117
, pp. 146-155
-
-
Farges, O.1
Malassagne, B.2
Sebagh, M.3
Bismuth, H.4
-
40
-
-
0025953324
-
Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation
-
40. Miros M, Kerlin P, Walker N, Harper J, Lynch S, Strong R. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation. Gut 1991; 32:1369-1373.
-
(1991)
Gut
, vol.32
, pp. 1369-1373
-
-
Miros, M.1
Kerlin, P.2
Walker, N.3
Harper, J.4
Lynch, S.5
Strong, R.6
-
41
-
-
0031914317
-
Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A casecontrol study
-
41. Bergquist A, Glaumann H, Persson B, Broomé U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a casecontrol study. Hepatology 1998; 27:311-316.
-
(1998)
Hepatology
, vol.27
, pp. 311-316
-
-
Bergquist, A.1
Glaumann, H.2
Persson, B.3
Broomé, U.4
-
42
-
-
0027268061
-
Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis
-
42. D'Haens GR, Lashner BA, Hanauer SB. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol 1993; 88:1174-1178.
-
(1993)
Am J Gastroenterol
, vol.88
, pp. 1174-1178
-
-
D'Haens, G.R.1
Lashner, B.A.2
Hanauer, S.B.3
-
43
-
-
0030024918
-
Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis
-
43. Brentnall TA, Haggitt RC, Rabinovitch PS, Kimmey MB, Bronner MP, Levine DS, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996; 110:331-338.
-
(1996)
Gastroenterology
, vol.110
, pp. 331-338
-
-
Brentnall, T.A.1
Haggitt, R.C.2
Rabinovitch, P.S.3
Kimmey, M.B.4
Bronner, M.P.5
Levine, D.S.6
-
44
-
-
0030023109
-
Risk of colorectal neoplasia in patients with primary sclerosing cholangitis
-
44. Loftus EVJ, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton LJ. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 1996; 110:432-440.
-
(1996)
Gastroenterology
, vol.110
, pp. 432-440
-
-
Loftus, E.V.J.1
Sandborn, W.J.2
Tremaine, W.J.3
Mahoney, D.W.4
Zinsmeister, A.R.5
Offord, K.P.6
Melton, L.J.7
-
45
-
-
0001478154
-
Risk factors for cancer or dysplasia in ulcerative colitis with Primary sclerosing Cholangitis
-
Abstract
-
45. Lashner BA, Shetty B, Rybicki L, Brzezinski A. Risk factors for cancer or dysplasia in ulcerative colitis with Primary Sclerosing Cholangitis. Gastroenterology 1998; 114:(Abstract).
-
(1998)
Gastroenterology
, vol.114
-
-
Lashner, B.A.1
Shetty, B.2
Rybicki, L.3
Brzezinski, A.4
-
46
-
-
0027376041
-
Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease
-
46. Bleday R, Lee E, Jessurun J, Heine J, Wong WD. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993; 36:908-912.
-
(1993)
Dis Colon Rectum
, vol.36
, pp. 908-912
-
-
Bleday, R.1
Lee, E.2
Jessurun, J.3
Heine, J.4
Wong, W.D.5
-
47
-
-
0028841737
-
Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential
-
47. Broomé U, Löfberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995; 22:1404-1408.
-
(1995)
Hepatology
, vol.22
, pp. 1404-1408
-
-
Broomé, U.1
Löfberg, R.2
Veress, B.3
Eriksson, L.S.4
-
48
-
-
0029563820
-
Coincidental cases of primary sclerosing cholangitis and biliary atresia in siblings?
-
48. Isoyama K, Yamada K, Ishikawa K, Sanada Y. Coincidental cases of primary sclerosing cholangitis and biliary atresia in siblings? Acta Paediatr 1995; 84:1444-1446.
-
(1995)
Acta Paediatr
, vol.84
, pp. 1444-1446
-
-
Isoyama, K.1
Yamada, K.2
Ishikawa, K.3
Sanada, Y.4
-
49
-
-
0020518009
-
Familial occurrence of primary sclerosing cholangitis and ulcerative colitis
-
49. Quigley EM, LaRusso NF, Ludwig J, MacSween RN, Birnie GG, Watkinson G. Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1983; 85:1160-1165.
-
(1983)
Gastroenterology
, vol.85
, pp. 1160-1165
-
-
Quigley, E.M.1
LaRusso, N.F.2
Ludwig, J.3
MacSween, R.N.4
Birnie, G.G.5
Watkinson, G.6
-
50
-
-
0028021772
-
Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis
-
50. Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenrerology 1994; 107:532-536.
-
(1994)
Gastroenrerology
, vol.107
, pp. 532-536
-
-
Seibold, F.1
Slametschka, D.2
Gregor, M.3
Weber, P.4
-
51
-
-
0029922356
-
Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative col itis
-
51. Bansi DS, Lo S, Chapman RW, Fleming KA. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative col itis. Eur J Gastroenterol Hepatol 1996; 8:111-116.
-
(1996)
Eur J Gastroenterol Hepatol
, vol.8
, pp. 111-116
-
-
Bansi, D.S.1
Lo, S.2
Chapman, R.W.3
Fleming, K.A.4
-
52
-
-
0020701653
-
Association of primary sclerosing cholangitis with HLA-B8
-
52. Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut 1983; 24:38-41.
-
(1983)
Gut
, vol.24
, pp. 38-41
-
-
Chapman, R.W.1
Varghese, Z.2
Gaul, R.3
Patel, G.4
Kokinon, N.5
Sherlock, S.6
-
53
-
-
0020043880
-
HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease
-
53. Schrumpf E, Fausa O, Forre O, Dobloug JH, Ritland S, Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 1982; 1982:187-191.
-
(1982)
Scand J Gastroenterol
, vol.1982
, pp. 187-191
-
-
Schrumpf, E.1
Fausa, O.2
Forre, O.3
Dobloug, J.H.4
Ritland, S.5
Thorsby, E.6
-
54
-
-
0025975965
-
Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis
-
54. Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 1991; 13:129-133.
-
(1991)
Hepatology
, vol.13
, pp. 129-133
-
-
Donaldson, P.T.1
Farrant, J.M.2
Wilkinson, M.L.3
Hayllar, K.4
Portmann, B.C.5
Williams, R.6
-
55
-
-
0025380531
-
Immunological aspects of diabetes
-
55. Che SA. Immunological aspects of diabetes. Recenti Prog Med 1990; 81:72-78.
-
(1990)
Recenti Prog Med
, vol.81
, pp. 72-78
-
-
Che, S.A.1
-
56
-
-
0025337272
-
Association of primary sclerosing cholangitis with HLA-DRw52a
-
56. Prochazka EJ, Terasaki PL, Park MS, Goldstein LL, Busuttil RW. Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med 1990; 322:1842-1844.
-
(1990)
N Engl J Med
, vol.322
, pp. 1842-1844
-
-
Prochazka, E.J.1
Terasaki, P.L.2
Park, M.S.3
Goldstein, L.L.4
Busuttil, R.W.5
-
57
-
-
0026093687
-
Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA DRw52 allele
-
Abstract
-
57. Park MS, Terasaki PL. Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA DRw52 allele [Reply to Letter]. N Engl J Med 1991; 325:1252, (Abstract).
-
(1991)
N Engl J Med
, vol.325
, pp. 1252
-
-
Park, M.S.1
Terasaki, P.L.2
-
58
-
-
0026093687
-
Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA DRw52 allele
-
Abstract
-
58. Mehal WZ, Wordsworth BP, Tayler CJ, Bell JL, Fleming KA, Chapman RW. Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA DRw52 allele [Letter]. N Engl J Med 1991; 325:1252 (Abstract).
-
(1991)
N Engl J Med
, vol.325
, pp. 1252
-
-
Mehal, W.Z.1
Wordsworth, B.P.2
Tayler, C.J.3
Bell, J.L.4
Fleming, K.A.5
Chapman, R.W.6
-
59
-
-
0026093687
-
Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA DRw52 allele
-
59. Olerup O, Broomé U, Einarsson K, Zetterquist H. Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA DRw52 allele [Letter]. N Engl J Med 1991; 325:1251, 1252.
-
(1991)
N Engl J Med
, vol.325
, pp. 1251
-
-
Olerup, O.1
Broomé, U.2
Einarsson, K.3
Zetterquist, H.4
-
60
-
-
0026643063
-
Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis
-
60. Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Hayllar KM, Welsh KI, et al. Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology 1992; 16:390-395.
-
(1992)
Hepatology
, vol.16
, pp. 390-395
-
-
Farrant, J.M.1
Doherty, D.G.2
Donaldson, P.T.3
Vaughan, R.W.4
Hayllar, K.M.5
Welsh, K.I.6
-
61
-
-
0028047221
-
HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis
-
61. Mehal WZ, Lo YM, Wordsworth BP, Neuberger JM, Hubscher SC, Fleming KA, Chapman RW. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1994; 106:160-167.
-
(1994)
Gastroenterology
, vol.106
, pp. 160-167
-
-
Mehal, W.Z.1
Lo, Y.M.2
Wordsworth, B.P.3
Neuberger, J.M.4
Hubscher, S.C.5
Fleming, K.A.6
Chapman, R.W.7
-
62
-
-
0028920393
-
HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis
-
62. Olerup O, Olsson R, Hultcrantz R, Broome U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1995; 108:870-878.
-
(1995)
Gastroenterology
, vol.108
, pp. 870-878
-
-
Olerup, O.1
Olsson, R.2
Hultcrantz, R.3
Broome, U.4
-
63
-
-
0003137624
-
Immunogenetics and epidemiology of primary sclerosing cholangitis
-
Manns MP, et al. (eds.). Dordrecht: Kluwer Academic Publishers
-
63. Donaldson PT. Immunogenetics and epidemiology of primary sclerosing cholangitis. In: Primary sclerosing cholangitis. Manns MP, et al. (eds.). Dordrecht: Kluwer Academic Publishers, 1998, pp. 22-36.
-
(1998)
Primary Sclerosing Cholangitis
, pp. 22-36
-
-
Donaldson, P.T.1
-
64
-
-
85037957466
-
HLA Class II haplotypes in primary sclerosing cholangitis patients from five ethnic groups
-
Abstract
-
64. Saarinen S, Boberg K, Spurkland A, Mitchell SA, Broomé U, Rosina F, Chapman RW. HLA Class II haplotypes in primary sclerosing cholangitis patients from five ethnic groups. Hepatology 1998; 28:445A (Abstract).
-
(1998)
Hepatology
, vol.28
-
-
Saarinen, S.1
Boberg, K.2
Spurkland, A.3
Mitchell, S.A.4
Broomé, U.5
Rosina, F.6
Chapman, R.W.7
-
65
-
-
0001144389
-
Do primary sclerosing cholangitis (PSC) patients who express HLA-dr4 haplotype have a more rapidly progress disease?
-
Abstract
-
65. Aguilar HI, Nuako K, Krom RA, Wiesner RH. Do primary sclerosing cholangitis (PSC) patients who express HLA-DR4 haplotype have a more rapidly progress disease? Hepatology 1994; 20:154A (Abstract).
-
(1994)
Hepatology
, vol.20
-
-
Aguilar, H.I.1
Nuako, K.2
Krom, R.A.3
Wiesner, R.H.4
-
66
-
-
4243277293
-
HLA DR4 and DR4 subtypes confer resistance to primary sclerosing cholangitis and are not associated with poor prognosis
-
Abstract
-
66. Moloney MM, Donaldson PT, Thomson LJ, Williams R. HLA DR4 and DR4 subtypes confer resistance to primary sclerosing cholangitis and are not associated with poor prognosis. Hepatology 1996; 24:169A (Abstract).
-
(1996)
Hepatology
, vol.24
-
-
Moloney, M.M.1
Donaldson, P.T.2
Thomson, L.J.3
Williams, R.4
-
67
-
-
85037968333
-
The HLA-DRB1*03, DQA1*0501, DQB1*02 (DR2,DR2) haplotype is associated with a more rapid disease progression in primary sclerosi ng cholangitis
-
Abstract
-
67. Boberg K, Rocca B, Spurkland A, Broomé U, Chapman R, Mitchell SA, et al. The HLA-DRB1*03, DQA1*0501, DQB1*02 (DR2,DR2) haplotype is associated with a more rapid disease progression in primary sclerosi ng cholangitis. Hepatology 1998; 28:445A (Abstract).
-
(1998)
Hepatology
, vol.28
-
-
Boberg, K.1
Rocca, B.2
Spurkland, A.3
Broomé, U.4
Chapman, R.5
Mitchell, S.A.6
-
68
-
-
0031752377
-
Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis
-
68. Moloney MM, Thomson LJ, Strettell MDJ, Williams R, Donaldson PT. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis. Hepatology 1998; 28:660-662.
-
(1998)
Hepatology
, vol.28
, pp. 660-662
-
-
Moloney, M.M.1
Thomson, L.J.2
Strettell, M.D.J.3
Williams, R.4
Donaldson, P.T.5
-
69
-
-
85037961311
-
Does TNF gene polymorphism determine susceptibility to primary sclerosing cholangitis?
-
Abstract
-
69. Bernal W, Moloney M, Underhill J, Donaldson P. Does TNF gene polymorphism determine susceptibility to primary sclerosing cholangitis? Hepatology 1997; 26:403A (Abstract).
-
(1997)
Hepatology
, vol.26
-
-
Bernal, W.1
Moloney, M.2
Underhill, J.3
Donaldson, P.4
-
70
-
-
0030007093
-
Contribution of genes of the major histocompatability complex to susceptibility and disease phenotype in inflammatory bowel disease
-
70. Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JL, Jewell DP. Contribution of genes of the major histocompatability complex to susceptibility and disease phenotype in inflammatory bowel disease. The Lancet 1996; 347:1212-1217.
-
(1996)
The Lancet
, vol.347
, pp. 1212-1217
-
-
Satsangi, J.1
Welsh, K.I.2
Bunce, M.3
Julier, C.4
Farrant, J.M.5
Bell, J.L.6
Jewell, D.P.7
-
71
-
-
0003270691
-
HLA associations in primary sclerosing cholangitis are present only in those patients with concurrent inflammatory bowel disease
-
Abstract
-
71. Donaldson P, Norris S, Underhill J, Constantini PK, Harrison PM. HLA associations in primary sclerosing cholangitis are present only in those patients with concurrent inflammatory bowel disease. Hepatology 1998; 28:392A (Abstract).
-
(1998)
Hepatology
, vol.28
-
-
Donaldson, P.1
Norris, S.2
Underhill, J.3
Constantini, P.K.4
Harrison, P.M.5
-
72
-
-
0018380080
-
Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases
-
72. McFarlane IG, Wojcicka BM, Tsantoulas DC, Portmann BC, Eddleston AL, Williams R. Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases. Gastroenterology 1979; 76:1333-1340.
-
(1979)
Gastroenterology
, vol.76
, pp. 1333-1340
-
-
McFarlane, I.G.1
Wojcicka, B.M.2
Tsantoulas, D.C.3
Portmann, B.C.4
Eddleston, A.L.5
Williams, R.6
-
73
-
-
0021826772
-
Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis
-
73. Whiteside TL, Lasky S, Si L, Van Thiel DH. Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology 1985; 5:468-474.
-
(1985)
Hepatology
, vol.5
, pp. 468-474
-
-
Whiteside, T.L.1
Lasky, S.2
Si, L.3
Van Thiel, D.H.4
-
74
-
-
0023213962
-
Lymphocyte subsets in primary sclerosing cholangitis
-
74. Lindor KD, Wiesner RH, Katzmann JA, LaRusso NF, Beaver SJ. Lymphocyte subsets in primary sclerosing cholangitis. Dig Dis Sci 1987; 32:720-725.
-
(1987)
Dig Dis Sci
, vol.32
, pp. 720-725
-
-
Lindor, K.D.1
Wiesner, R.H.2
Katzmann, J.A.3
LaRusso, N.F.4
Beaver, S.J.5
-
75
-
-
0024353808
-
Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis
-
75. Snook JA, Chapman RW, Sachdev GK, Heryet A, Kelly PM, Fleming KA, Jewell DP. Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis. J Hepatol 1989; 9:36-41.
-
(1989)
J Hepatol
, vol.9
, pp. 36-41
-
-
Snook, J.A.1
Chapman, R.W.2
Sachdev, G.K.3
Heryet, A.4
Kelly, P.M.5
Fleming, K.A.6
Jewell, D.P.7
-
76
-
-
0024512001
-
Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood
-
76. Mieli-Vergani G, Lobo-Yeo A, McFarlane BM, McFarlane IG, Mowat AP, Vergani D. Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology 1989; 9:198-203.
-
(1989)
Hepatology
, vol.9
, pp. 198-203
-
-
Mieli-Vergani, G.1
Lobo-Yeo, A.2
McFarlane, B.M.3
McFarlane, I.G.4
Mowat, A.P.5
Vergani, D.6
-
77
-
-
0008315370
-
Increased activation of peripheral blood and liver T-lymphocytes in patients with primary sclerosing cholangitis and autoimmune liver diseases
-
Abstract
-
77. Martins EB, Healey CJ, Chapman RW, Fleming K. Increased activation of peripheral blood and liver T-lymphocytes in patients with primary sclerosing cholangitis and autoimmune liver diseases. Hepatology 1994; 19:981 (Abstract).
-
(1994)
Hepatology
, vol.19
, pp. 981
-
-
Martins, E.B.1
Healey, C.J.2
Chapman, R.W.3
Fleming, K.4
-
79
-
-
0021246718
-
Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: Morphologic spectrum, clinical correlations and terminology
-
79. Ludwig J, Czaja AJ, Dickson ER, LaRusso NF, Wiesner RH. Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology. Liver 1984; 4:105-116.
-
(1984)
Liver
, vol.4
, pp. 105-116
-
-
Ludwig, J.1
Czaja, A.J.2
Dickson, E.R.3
LaRusso, N.F.4
Wiesner, R.H.5
-
80
-
-
0021927412
-
Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis
-
80. Wiesner RH, LaRusso NF, Ludwig J, Dickson ER. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 1985; 88:108-114.
-
(1985)
Gastroenterology
, vol.88
, pp. 108-114
-
-
Wiesner, R.H.1
LaRusso, N.F.2
Ludwig, J.3
Dickson, E.R.4
-
81
-
-
0027141317
-
Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis
-
81. Hashimoto E, Lindor KD, Homburger HA, Dickson ER, Czaja AJ, Wiesner RH, Ludwig J. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc 1993; 68:1049-1055.
-
(1993)
Mayo Clin Proc
, vol.68
, pp. 1049-1055
-
-
Hashimoto, E.1
Lindor, K.D.2
Homburger, H.A.3
Dickson, E.R.4
Czaja, A.J.5
Wiesner, R.H.6
Ludwig, J.7
-
82
-
-
0021638394
-
T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls
-
82. Si L, Whiteside TL, Schade RR, Starzl TE, Van Thiel DH. T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls. J Clin Immunol 1984; 4:262-272.
-
(1984)
J Clin Immunol
, vol.4
, pp. 262-272
-
-
Si, L.1
Whiteside, T.L.2
Schade, R.R.3
Starzl, T.E.4
Van Thiel, D.H.5
-
83
-
-
0026677933
-
Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis
-
83. Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D. Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. Arch Dis Child 1992; 67:1447-1453.
-
(1992)
Arch Dis Child
, vol.67
, pp. 1447-1453
-
-
Senaldi, G.1
Portmann, B.2
Mowat, A.P.3
Mieli-Vergani, G.4
Vergani, D.5
-
84
-
-
0026566475
-
Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease
-
84. Hata K, Van Thiel DH, Herberman RB, Whiteside TL. Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease. Hepatology 1992; 15:816-823.
-
(1992)
Hepatology
, vol.15
, pp. 816-823
-
-
Hata, K.1
Van Thiel, D.H.2
Herberman, R.B.3
Whiteside, T.L.4
-
85
-
-
0023910783
-
Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis
-
85. Chapman RW, Kelly PM, Heryet A, Jewell DP, Fleming KA. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut 1988; 29:422-427.
-
(1988)
Gut
, vol.29
, pp. 422-427
-
-
Chapman, R.W.1
Kelly, P.M.2
Heryet, A.3
Jewell, D.P.4
Fleming, K.A.5
-
86
-
-
0025139445
-
Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis
-
86. Broomé U, Glaumann H, Hultcrantz R, Forsum U. Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis. Scand J Gastroenterol 1990; 25:54-58.
-
(1990)
Scand J Gastroenterol
, vol.25
, pp. 54-58
-
-
Broomé, U.1
Glaumann, H.2
Hultcrantz, R.3
Forsum, U.4
-
87
-
-
0026042723
-
Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis
-
87. Adams DH, Hubscher SG, Shaw J, Johnson GD, Babbs C, Rothlein R, Neuberger JM. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991; 14:426-431.
-
(1991)
Hepatology
, vol.14
, pp. 426-431
-
-
Adams, D.H.1
Hubscher, S.G.2
Shaw, J.3
Johnson, G.D.4
Babbs, C.5
Rothlein, R.6
Neuberger, J.M.7
-
88
-
-
0028946215
-
Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis
-
88. Bloom S, Fleming K, Chapman R. Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis. Gut 1995; 36:604-609.
-
(1995)
Gut
, vol.36
, pp. 604-609
-
-
Bloom, S.1
Fleming, K.2
Chapman, R.3
-
89
-
-
0030059329
-
Biliary expression of heat shock protein: A non-specific feature of chronic cholestatic liver diseases
-
89. Martins EB, Chapman RW, Marron K, Fleming KA. Biliary expression of heat shock protein: a non-specific feature of chronic cholestatic liver diseases. J Clin Pathol 1996; 49:53-56.
-
(1996)
J Clin Pathol
, vol.49
, pp. 53-56
-
-
Martins, E.B.1
Chapman, R.W.2
Marron, K.3
Fleming, K.A.4
-
90
-
-
0027292904
-
Inappropriate expression of blood group antigens on biliary and colonic epithelia in primary sclerosing cholangitis
-
90. Bloom S, Heryet A, Fleming K, Chapman RW. Inappropriate expression of blood group antigens on biliary and colonic epithelia in primary sclerosing cholangitis. Gut 1993; 34:977-983.
-
(1993)
Gut
, vol.34
, pp. 977-983
-
-
Bloom, S.1
Heryet, A.2
Fleming, K.3
Chapman, R.W.4
-
91
-
-
0024521001
-
The relationship between HLA-DR3 and T-cell regulation of immunoglobulin production in primary sclerosing cholangitis
-
91. Magrin S, Nouri-Aria KT, Donaldson PT, Wilkinson ML, Portmann BC, Williams R, Eddleston AL. The relationship between HLA-DR3 and T-cell regulation of immunoglobulin production in primary sclerosing cholangitis. Clin Immunol Immunopathol 1989; 50:205-212.
-
(1989)
Clin Immunol Immunopathol
, vol.50
, pp. 205-212
-
-
Magrin, S.1
Nouri-Aria, K.T.2
Donaldson, P.T.3
Wilkinson, M.L.4
Portmann, B.C.5
Williams, R.6
Eddleston, A.L.7
-
92
-
-
0023638478
-
Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis
-
92. Lindor KD, Wiesner RH, LaRusso NF, Homburger HA. Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis. Hepatology 1987; 7:884-888.
-
(1987)
Hepatology
, vol.7
, pp. 884-888
-
-
Lindor, K.D.1
Wiesner, R.H.2
LaRusso, N.F.3
Homburger, H.A.4
-
93
-
-
4243930363
-
Activated lymphocytes in the liver of patients with primary sclerosing cholangitis: Results of a morphometric study
-
Abstract
-
93. Martins EB, Graham AK, Healey CJ, Chapman RW, Fleming KA. Activated lymphocytes in the liver of patients with primary sclerosing cholangitis: results of a morphometric study. Gut 1994; 35:S20 (Abstract).
-
(1994)
Gut
, vol.35
-
-
Martins, E.B.1
Graham, A.K.2
Healey, C.J.3
Chapman, R.W.4
Fleming, K.A.5
-
94
-
-
0025955173
-
Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: Increase in activated T and natural killer cells and recruitment of primed memory T cells
-
94. Bjorkland A, Festin R, Mendel-Hartvig I, Nyberg A, Lööf L, Totterman TH. Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: increase in activated T and natural killer cells and recruitment of primed memory T cells. Hepatology 1991; 13:1106-1111.
-
(1991)
Hepatology
, vol.13
, pp. 1106-1111
-
-
Bjorkland, A.1
Festin, R.2
Mendel-Hartvig, I.3
Nyberg, A.4
Lööf, L.5
Totterman, T.H.6
-
95
-
-
0027092667
-
T-cell subsets in autoimmunity
-
95. Mason D, Fowell D. T-cell subsets in autoimmunity. Curr Opin Immunol 1992; 4:728-732.
-
(1992)
Curr Opin Immunol
, vol.4
, pp. 728-732
-
-
Mason, D.1
Fowell, D.2
-
96
-
-
0030941082
-
A T helper cell 2 (Th2) immune response against nonself antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis
-
96. Falcone M, Bloom BR. A T helper cell 2 (Th2) immune response against nonself antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J Exp Med 1997; 185:901-907.
-
(1997)
J Exp Med
, vol.185
, pp. 901-907
-
-
Falcone, M.1
Bloom, B.R.2
-
97
-
-
0029838995
-
Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
-
97. Mueller R, Krahl T, Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 1996; 184:1093-1099.
-
(1996)
J Exp Med
, vol.184
, pp. 1093-1099
-
-
Mueller, R.1
Krahl, T.2
Sarvetnick, N.3
-
98
-
-
0026508833
-
Decreased in vitro production of tumor necrosis factor in primary biliary cirrhosis patients
-
98. Broomé U, Eriksson LS, Sundin U, Sundqvist KG. Decreased in vitro production of tumor necrosis factor in primary biliary cirrhosis patients. Scand J Gastroenterol 1992; 27:124-128.
-
(1992)
Scand J Gastroenterol
, vol.27
, pp. 124-128
-
-
Broomé, U.1
Eriksson, L.S.2
Sundin, U.3
Sundqvist, K.G.4
-
99
-
-
85037964812
-
Cytokine profile in autoimmune liver diseases using the reverse haemolytic plaque assay
-
Abstract
-
99. Martins EB, Lewis CE, Fleming KA, Chapman RW. Cytokine profile in autoimmune liver diseases using the reverse haemolytic plaque assay. Gut 1994; 35:S10 (Abstract).
-
(1994)
Gut
, vol.35
-
-
Martins, E.B.1
Lewis, C.E.2
Fleming, K.A.3
Chapman, R.W.4
-
100
-
-
0031413160
-
Serum levels of interleukins 8 and 10, interferon gamma, granulocytemacrophage colony stimulating factor and soluble CD23 in patients with primary sclerosing cholangitis
-
100. Bansal AS, Thomson A, Steadman C, Le Gros G, Hogan PG, Kerlin P, et al. Serum levels of interleukins 8 and 10, Interferon gamma, granulocytemacrophage colony stimulating factor and soluble CD23 in patients with primary sclerosing cholangitis. Autoimmunity 1997; 26:223-229.
-
(1997)
Autoimmunity
, vol.26
, pp. 223-229
-
-
Bansal, A.S.1
Thomson, A.2
Steadman, C.3
Le Gros, G.4
Hogan, P.G.5
Kerlin, P.6
-
101
-
-
0008317719
-
TH1-and TH2-cytokine profiles in autoimmune liver disorders
-
Abstract
-
101. Klein R, Leuschner M, Leuschner U, Berg PA. TH1-and TH2-cytokine profiles in autoimmune liver disorders. J Hepatol 1997; 26:112 (Abstract).
-
(1997)
J Hepatol
, vol.26
, pp. 112
-
-
Klein, R.1
Leuschner, M.2
Leuschner, U.3
Berg, P.A.4
-
102
-
-
0001225870
-
Enhanced cytokine mRNA expression in primary sclerosing cholangitis and autoimmune liver disease
-
Abstract
-
102. Mitchell SA, Chapman RW, Fleming KA. Enhanced cytokine mRNA expression in primary sclerosing cholangitis and autoimmune liver disease. Gastroenterology 1997; 112:A757 (Abstract).
-
(1997)
Gastroenterology
, vol.112
-
-
Mitchell, S.A.1
Chapman, R.W.2
Fleming, K.A.3
-
103
-
-
4243262929
-
Decreased interleukin-10 mRNA expression in primary sclerosing cholangitis and primary biliary cirrhosis: A role for IL-10 in the pathogenesis?
-
Abstract
-
103. Mitchell SA, Fleming K, Chapman RW. Decreased interleukin-10 mRNA expression in primary sclerosing cholangitis and primary biliary cirrhosis: a role for IL-10 in the pathogenesis? Hepatology 1997; 26:442A (Abstract).
-
(1997)
Hepatology
, vol.26
-
-
Mitchell, S.A.1
Fleming, K.2
Chapman, R.W.3
-
104
-
-
0031446766
-
Gamma delta cells regulate autoimmunity
-
104. Hayday A, Geng L. Gamma delta cells regulate autoimmunity. Curr Opin Immunol 1997; 9:884-889.
-
(1997)
Curr Opin Immunol
, vol.9
, pp. 884-889
-
-
Hayday, A.1
Geng, L.2
-
105
-
-
0027213197
-
Gamma delta lymphocytes in endocrine autoimmunity: Evidence of expansion in Graves' disease but not in type 1 diabetes
-
105. Roura-Mir IC, Alcalde L, Vargas F, Tolosa E, Obiols G, Foz M, et al. Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes. Clin Exp Immunol 1993; 92:288-295.
-
(1993)
Clin Exp Immunol
, vol.92
, pp. 288-295
-
-
Roura-Mir, I.C.1
Alcalde, L.2
Vargas, F.3
Tolosa, E.4
Obiols, G.5
Foz, M.6
-
106
-
-
0008353836
-
γ/δ + T clones from liver biopsies of children with autoimmune chronic active hepatitis and primary sclerosing cholangitis are cytotoxic to human liver target cells
-
Abstract
-
106. Wen L, Peakman M, Mowat AP, Mieli-Vergani G, Vergani D. γ/δ + T clones from liver biopsies of children with autoimmune chronic active hepatitis and primary sclerosing cholangitis are cytotoxic to human liver target cells. J Hepatol 1991; 13:80 (Abstract).
-
(1991)
J Hepatol
, vol.13
, pp. 80
-
-
Wen, L.1
Peakman, M.2
Mowat, A.P.3
Mieli-Vergani, G.4
Vergani, D.5
-
107
-
-
0029979464
-
Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases
-
107. Martins EB, Graham AK, Chapman RW, Fleming KA. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology 1996; 23:988-993.
-
(1996)
Hepatology
, vol.23
, pp. 988-993
-
-
Martins, E.B.1
Graham, A.K.2
Chapman, R.W.3
Fleming, K.A.4
-
108
-
-
0026509605
-
T cell receptor repertoire of infiltrating T cells in lips of Sjögren's syndrome patients
-
Published erratum appears in J Clin Invest 1992; 90(1):293.
-
108. Sumida T, Yonaha F, Maeda T, Tanabe E, Kolke T, Tomioka H, Yoshida S. T cell receptor repertoire of infiltrating T cells in lips of Sjögren's syndrome patients. J Clin Invest 1992; 89:681-685. (Published erratum appears in J Clin Invest 1992; 90(1):293.).
-
(1992)
J Clin Invest
, vol.89
, pp. 681-685
-
-
Sumida, T.1
Yonaha, F.2
Maeda, T.3
Tanabe, E.4
Kolke, T.5
Tomioka, H.6
Yoshida, S.7
-
109
-
-
0027365824
-
T cell repertoire and autoimmune diseases
-
109. Imberti L, Sottini A, Primi D. T cell repertoire and autoimmune diseases. Immunol Res 1993; 12:149-167.
-
(1993)
Immunol Res
, vol.12
, pp. 149-167
-
-
Imberti, L.1
Sottini, A.2
Primi, D.3
-
110
-
-
0030615212
-
Preferential V beta3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis
-
110. Broomé U, Grunewald J, Scheynius A, Olerup O, Hultcrantz R. Preferential V beta3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis. J Hepatol 1997; 26:527-534.
-
(1997)
J Hepatol
, vol.26
, pp. 527-534
-
-
Broomé, U.1
Grunewald, J.2
Scheynius, A.3
Olerup, O.4
Hultcrantz, R.5
-
111
-
-
0030822295
-
The CD28-B7 costimulatory pathway and its role in autoimmune disease
-
111. Daikh D, Wofsy D, Imboden JB. The CD28-B7 costimulatory pathway and its role in autoimmune disease. J Leukoc Biol 1997; 62:156-162.
-
(1997)
J Leukoc Biol
, vol.62
, pp. 156-162
-
-
Daikh, D.1
Wofsy, D.2
Imboden, J.B.3
-
112
-
-
0030825092
-
Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis
-
112. Dienes HP, Lohse AW, Gerken G, Schirmacher P, Gallati H, Löhr HF, Meyer zBK. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch 1997; 431:119-124.
-
(1997)
Virchows Arch
, vol.431
, pp. 119-124
-
-
Dienes, H.P.1
Lohse, A.W.2
Gerken, G.3
Schirmacher, P.4
Gallati, H.5
Löhr, H.F.6
Meyer, Z.B.K.7
-
113
-
-
4243557396
-
Are bile duct epithelial cells capable of acting as professional antigen presenting cells in primary sclerosing cholangitis?
-
Abstract
-
113. Martins EB, Chapman RW, Fleming KA. Are bile duct epithelial cells capable of acting as professional antigen presenting cells in primary sclerosing cholangitis? Hepatology 1995; 22:109A (Abstract).
-
(1995)
Hepatology
, vol.22
-
-
Martins, E.B.1
Chapman, R.W.2
Fleming, K.A.3
-
114
-
-
0031015099
-
Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis
-
114. Spengler U, Leifeld L, Braunschweiger I, Dumoulin FL, Lechmann M, Sauerbruch T. Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis. J Hepatol 1997; 26:31-36.
-
(1997)
J Hepatol
, vol.26
, pp. 31-36
-
-
Spengler, U.1
Leifeld, L.2
Braunschweiger, I.3
Dumoulin, F.L.4
Lechmann, M.5
Sauerbruch, T.6
-
115
-
-
0028999713
-
Immunogenicity of biliary epithelial cells: Study of expression of B7 molecules
-
115. Leon MP, Kirby JA, Gibbs P, Burt AD, Bassendine MF. Immunogenicity of biliary epithelial cells: study of expression of B7 molecules. J Hepatol 1995; 22:591-595.
-
(1995)
J Hepatol
, vol.22
, pp. 591-595
-
-
Leon, M.P.1
Kirby, J.A.2
Gibbs, P.3
Burt, A.D.4
Bassendine, M.F.5
-
116
-
-
0029844861
-
Immunogenicity of biliary epithelium: Investigation of antigen presentation to CD4+ T cells
-
116. Leon MP, Bassendine MF, Wilson JL, Ali S, Thick M, Kirby JA. Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells. Hepatology 1996; 24:561-567.
-
(1996)
Hepatology
, vol.24
, pp. 561-567
-
-
Leon, M.P.1
Bassendine, M.F.2
Wilson, J.L.3
Ali, S.4
Thick, M.5
Kirby, J.A.6
-
117
-
-
0020665063
-
Elevated circulating immune complexes in primary sclerosing cholangitis
-
117. Bodenheimer HCJ, LaRusso NF, Thayer WRJ, Charland C, Staples PJ, Ludwig J. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983; 3:150-154.
-
(1983)
Hepatology
, vol.3
, pp. 150-154
-
-
Bodenheimer, H.C.J.1
LaRusso, N.F.2
Thayer, W.R.J.3
Charland, C.4
Staples, P.J.5
Ludwig, J.6
-
118
-
-
0024398447
-
Activation of the complement system in primary sclerosing cholangitis
-
118. Senaldi G, Donaldson PT, Magrin S, Farrant JM, Alexander GJ, Vergani D, Williams R. Activation of the complement system in primary sclerosing cholangitis. Gastroenterology 1989; 97:1430-1434.
-
(1989)
Gastroenterology
, vol.97
, pp. 1430-1434
-
-
Senaldi, G.1
Donaldson, P.T.2
Magrin, S.3
Farrant, J.M.4
Alexander, G.J.5
Vergani, D.6
Williams, R.7
-
119
-
-
0027769965
-
Deposition of C3, the terminal complement complex and vitronectin in primary biliary cirrhosis and primary sclerosing cholangitis
-
119. Garred P, Lyon H, Christoffersen P, Mollnes TE, Tranum-Jensen J. Deposition of C3, the terminal complement complex and vitronectin in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 1993; 13:305-310.
-
(1993)
Liver
, vol.13
, pp. 305-310
-
-
Garred, P.1
Lyon, H.2
Christoffersen, P.3
Mollnes, T.E.4
Tranum-Jensen, J.5
-
121
-
-
0025910090
-
Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis
-
121. Duerr RH, Targan SR, Landers CL LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100:1385-1391.
-
(1991)
Gastroenterology
, vol.100
, pp. 1385-1391
-
-
Duerr, R.H.1
Targan, S.R.2
Landers, C.L.3
LaRusso, N.F.4
Lindsay, K.L.5
Wiesner, R.H.6
Shanahan, F.7
-
122
-
-
0026709891
-
Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique
-
122. Lo SK, Fleming KA, Chapman RW. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut 1992; 33:1370-1375.
-
(1992)
Gut
, vol.33
, pp. 1370-1375
-
-
Lo, S.K.1
Fleming, K.A.2
Chapman, R.W.3
-
123
-
-
0026518819
-
Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis
-
123. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992; 33:657-662.
-
(1992)
Gut
, vol.33
, pp. 657-662
-
-
Seibold, F.1
Weber, P.2
Klein, R.3
Berg, P.A.4
Wiedmann, K.H.5
-
124
-
-
0028624705
-
A 2-year follow-up study of antineutrophil antibody in primary sclerosing cholangitis: Relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment
-
124. Lo SK, Fleming KA, Chapman RW. A 2-year follow-up study of antineutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment. J Hepatol 1994; 21:974-978.
-
(1994)
J Hepatol
, vol.21
, pp. 974-978
-
-
Lo, S.K.1
Fleming, K.A.2
Chapman, R.W.3
-
125
-
-
12044257816
-
Serum antineutrophil cytoplasmic autoantibodies in inflammatory 7owel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment
-
125. Oudkerk PM, Ellerbroek PM, Ridwan BU, Goldschmeding R, von Blomberg BM, Pena AS, et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory 7owel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut 1993; 34:46-50.
-
(1993)
Gut
, vol.34
, pp. 46-50
-
-
Oudkerk, P.M.1
Ellerbroek, P.M.2
Ridwan, B.U.3
Goldschmeding, R.4
Von Blomberg, B.M.5
Pena, A.S.6
-
126
-
-
0031861647
-
Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis
-
126. Orth T, Kellner R, Diekmann O, Faust J, Meyer zBK, Mayet WJ. Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol 1998; 112:507-515.
-
(1998)
Clin Exp Immunol
, vol.112
, pp. 507-515
-
-
Orth, T.1
Kellner, R.2
Diekmann, O.3
Faust, J.4
Meyer, Z.5
Mayet, W.J.6
-
127
-
-
0030014042
-
Antineutrophil cytoplasmic antibodies in chronic liver diseases: Prevalence, titre, specificity and IgG subclass
-
127. Bansi D, Chapman R, Fleming K. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass. J Hepatol 1996; 24:581-586.
-
(1996)
J Hepatol
, vol.24
, pp. 581-586
-
-
Bansi, D.1
Chapman, R.2
Fleming, K.3
-
128
-
-
0030781954
-
Anti-neutrophil cytoplasmic antibodies in T-cell receptor α-deficient mice with chronic colitis
-
128. Mizoguchi E, Mizoguchi A, Chiba C. Anti-neutrophil cytoplasmic antibodies in T-cell receptor α-deficient mice with chronic colitis. Gastroenterology 1997; 113:1828-1835.
-
(1997)
Gastroenterology
, vol.113
, pp. 1828-1835
-
-
Mizoguchi, E.1
Mizoguchi, A.2
Chiba, C.3
-
129
-
-
0013864855
-
Primary sclerosing cholangitis. A study of forty-two cases
-
129. Warren KW, Athanassiades S, Monge JL. Primary sclerosing cholangitis. A study of forty-two cases. Am J Surg 1966; 111:23-38.
-
(1966)
Am J Surg
, vol.111
, pp. 23-38
-
-
Warren, K.W.1
Athanassiades, S.2
Monge, J.L.3
-
131
-
-
0008319862
-
Bile acids, cirrhosis and human evolution
-
131. Carey JB. Bile acids, cirrhosis and human evolution. Gastroenterology 1964; 46:490-492.
-
(1964)
Gastroenterology
, vol.46
, pp. 490-492
-
-
Carey, J.B.1
-
132
-
-
85037963289
-
Biliary lactoferrin concentrations are increased in active inflammatory bowel disease (IBD): A factor in the pathogenesis of primary sclerosing cholangitis?
-
Abstract
-
132. Pereira SP, Rhodes JM, Bain IM, Kumar D, Murphy GM, Dowling RH. Biliary lactoferrin concentrations are increased in active inflammatory bowel disease (IBD): a factor in the pathogenesis of primary sclerosing cholangitis? Gut 1995; 36:A56 (Abstract).
-
(1995)
Gut
, vol.36
-
-
Pereira, S.P.1
Rhodes, J.M.2
Bain, I.M.3
Kumar, D.4
Murphy, G.M.5
Dowling, R.H.6
-
133
-
-
0028084463
-
Kinetics of hepatic bile acid handling in cholestatic liver disease: Effect of ursodeoxychol ic acid
-
133. Jazrawi RP, de Caestecker JS, Goggin PM, Britten AJ, Joseph AK, Maxwell JD, Northfield TC. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxychol ic acid. Gastroenterology 1994; 106:134-142.
-
(1994)
Gastroenterology
, vol.106
, pp. 134-142
-
-
Jazrawi, R.P.1
De Caestecker, J.S.2
Goggin, P.M.3
Britten, A.J.4
Joseph, A.K.5
Maxwell, J.D.6
Northfield, T.C.7
-
134
-
-
0001225870
-
High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind placebo-controlled trial
-
Abstract
-
134. Mitchell SA, Bansi D, Hunt N, Christie J, Fleming K, Chapman R. High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): results after two years of a randomised double-blind placebo-controlled trial. Gastroenterology 1997; 112:A757 (Abstract).
-
(1997)
Gastroenterology
, vol.112
-
-
Mitchell, S.A.1
Bansi, D.2
Hunt, N.3
Christie, J.4
Fleming, K.5
Chapman, R.6
-
135
-
-
0031047361
-
Ursodiol for primary sclerosing cholangitis
-
135. Lindor KD, The Mayo PSC/UDCA Study Group. Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997; 336:691-695.
-
(1997)
N Engl J Med
, vol.336
, pp. 691-695
-
-
Lindor, K.D.1
-
137
-
-
0000796368
-
A controlled clinical trial evaluating cyclosporine in the treatment of primary sclerosing cholangitis
-
Abstract
-
137. Wiesner RH, Steiner B, LaRusso NF, Lindor KD, Baldus WP. A controlled clinical trial evaluating cyclosporine in the treatment of primary sclerosing cholangitis. Hepatology 1991; 14:63A (Abstract).
-
(1991)
Hepatology
, vol.14
-
-
Wiesner, R.H.1
Steiner, B.2
LaRusso, N.F.3
Lindor, K.D.4
Baldus, W.P.5
-
138
-
-
0028939546
-
Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: Results of an open-label preliminary trial
-
138. Van Thiel DH, Carroll P, Abu EK, Rodriguez RH, Irish W, McMichael J, Starzl TE. Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. Am J Gastroenterol 1995; 90:455-459.
-
(1995)
Am J Gastroenterol
, vol.90
, pp. 455-459
-
-
Van Thiel, D.H.1
Carroll, P.2
Abu, E.K.3
Rodriguez, R.H.4
Irish, W.5
McMichael, J.6
Starzl, T.E.7
-
139
-
-
0028123403
-
A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis
-
139. Knox TA, Kaplan MM. A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 1994; 106:494-499.
-
(1994)
Gastroenterology
, vol.106
, pp. 494-499
-
-
Knox, T.A.1
Kaplan, M.M.2
-
140
-
-
0023688260
-
Prospective trial of penicillamine in primary sclerosing cholangitis
-
140. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL, Beaver SJ, Zinsmeister AR. Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 1988; 95:1036-1042.
-
(1988)
Gastroenterology
, vol.95
, pp. 1036-1042
-
-
LaRusso, N.F.1
Wiesner, R.H.2
Ludwig, J.3
Maccarty, R.L.4
Beaver, S.J.5
Zinsmeister, A.R.6
-
141
-
-
0028924487
-
Colchicine treatment of primary sclerosing cholangitis
-
141. Olsson R, Broomé U, Danielsson A, Hägerstrand I, Järnerot G, Lööf L, Prytz H, Rydén BO, Wallerstedt S. Colchicine treatment of primary sclerosing cholangitis. Gastroenterology 1995; 108:1199-1203.
-
(1995)
Gastroenterology
, vol.108
, pp. 1199-1203
-
-
Olsson, R.1
Broomé, U.2
Danielsson, A.3
Hägerstrand, I.4
Järnerot, G.5
Lööf, L.6
Prytz, H.7
Rydén, B.O.8
Wallerstedt, S.9
-
142
-
-
0027272611
-
Biliary strictures in hepatic transplants: Prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases
-
142. Sheng R, Zajko AB, Campbell WL, Abu-Elmagd K. Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases. AJR 1993; 161:297-300.
-
(1993)
AJR
, vol.161
, pp. 297-300
-
-
Sheng, R.1
Zajko, A.B.2
Campbell, W.L.3
Abu-Elmagd, K.4
-
143
-
-
0027979016
-
Fibrous and obliterative cholangitis in liver allografts: Evidence of recurrent primary sclerosing cholangitis?
-
143. Harrison RF, Davies MH, Neuberger JM, Hubscher SG. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? Hepatology 1994; 20:356-361.
-
(1994)
Hepatology
, vol.20
, pp. 356-361
-
-
Harrison, R.F.1
Davies, M.H.2
Neuberger, J.M.3
Hubscher, S.G.4
-
144
-
-
0023818968
-
Enterohepatic circulation of bacterial chemotatic peptide in rats with experimental colitis
-
144. Hobson CH, Butt TJ, Ferry DM, Hunter J, Chadwick VS. Enterohepatic circulation of bacterial chemotatic peptide in rats with experimental colitis. Gastroenterology 1988; 94:1006-1013.
-
(1988)
Gastroenterology
, vol.94
, pp. 1006-1013
-
-
Hobson, C.H.1
Butt, T.J.2
Ferry, D.M.3
Hunter, J.4
Chadwick, V.S.5
-
145
-
-
0023869711
-
Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits
-
145. Kono K, Ohnishi K, Omata M, Saito M, Nakayama T. Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. Gastroenterology 1988; 94:787-796.
-
(1988)
Gastroenterology
, vol.94
, pp. 787-796
-
-
Kono, K.1
Ohnishi, K.2
Omata, M.3
Saito, M.4
Nakayama, T.5
|